Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases - Hoessel,R.; Leclerc,S.; Endicott,J.A.; Nobel,M.E.; Lawrie,A.; Tunnah,P.; Leost,M.; Damiens,E.; Marie,D.; Marko,D.; Niederberger,E.; Tang,W.; et al. (Nature Cell Biology, 1999)